Role of proteinuria in the regulation of renal renin-angiotensin system components in unilateral proteinuric rats

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 4, Issue 1, 2003, Pages 38-42

  Deelman, Leo E ^a   Navis, Gerjan ^b   de Boer, Erik ^b   Wietses, Mirian ^a   de Zeeuw, Dick ^a   Henning, Robert H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ACE; Adriamycin; Angiotensin; Rats; Transforming growth factor

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; DOXORUBICIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MESSENGER RNA; PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME REGULATION; GROWTH RATE; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION;

EID: 0347078312     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2003.006     Document Type: Article

References (19)

1. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990;38:384-94.
2. de-Keijzer MH, Provoost AP, Molenaar JC. Proteinuria is an early marker in the development of progressive renal failure in hypertensive fawn-hooded rats. J Hypertens 1989;7:525-8.
3. De Boer E, Navis G, Tiebosch AT, De Jong PE, de Zeeuw D. Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats. J Am Soc Nephrol 1999;10:2359-66.
4. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-63.
5. Wapstra FH, Navis G, De Jong PE, de Zeeuw D. Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis. J Am Soc Nephrol 2000;11:490-6.
6. Wapstra FH, Van Goor H, Navis GJ, De Jong PE, de Zeeuw D. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. Clin Sci (Colch) 1996;90:393-401.
7. Maschio G, Alberti D, Janin G et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996;334:939-45.
8. Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 1998;40:352-63.
9. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-61.
10. Griendling KK, Berk BC, Socorro L, Tsuda T, Delafontaine P, Alexander RW. Secondary signalling mechanisms in angiotensin II-stimulated vascular smooth muscle cells. Clin Exp Pharmacol Physiol 1988;15:105-12.
11. Baroni EA, Costa RS, Volpini R, Coimbra TM. Sodium bicarbonate treatment reduces renal injury, renal production of transforming growth factor-beta, and urinary transforming growth factor-beta excretion in rats with doxorubicin-induced nephropathy. Am J Kidney Dis 1999;34:328-37.
12. Sharma K, Wang L, Zhu Y, Bokkala S, Joseph SK. Transforming growth factor-beta1 inhibits type I inositol 1,4,5-trisphosphate receptor expression and enhances its phosphorylation in mesangial cells. J Biol Chem 1997;272:14617-23.
13. Sharma K, Jin Y, Guo J, Ziyadeh FN. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996;45:522-30.
14. Brundel BJ, Van Gelder IC, Henning RH et al, Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc Res 1999;42:443-54.
15. Largo R, Gomez-Garre D, Soto K et al. Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 1999;33:732-9.
16. Morrissey JJ, Klahr S. Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol 1999;276(1 Pt 2):F39-F45.
17. Stoneking BJ, Hunley TE, Nishimura H et al. Renal angiotensin converting enzyme promotes renal damage during ureteral obstruction. J Urol 1998;160(3 Pt 2):1070-4.
18. Tamaki K, Okuda S, Miyazono K, Nakayama M, Fujishima M. Matrix-associated latent TGF-beta with latent TGF-beta binding protein in the progressive process in adriamycin-induced nephropathy. Lab Invest 1995;73:81-9.
19. Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama M, Fujishima M. TGF-beta 1 in glomerulosclerosis; and interstitial fibrosis of adriamycin nephropathy. Kidney Int 1994;45:525-36.